ArticleThe Journal of infection2026
Multi-strain Clostridioides difficile infection: Increased detection and clinical implications.
Article in The Journal of infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Clostridioides difficile infection (CDI) is an antibiotic-associated diarrheal disease. Mixed infection has been previously reported. However, its clinical implications are not well defined. In this study, we evaluated the presence of multi-strain (MS) isolates in fecal specimens from patients diagnosed with CDI at a tertiary hospital in Virginia. C. difficile colonies (three per sample) were obtained from fecal specimen cultures (N=174) from patients diagnosed with CDI from April 2021 to February 2022. The toxin gene profile of each isolate was determined by PCR using specific primers for triose phosphate isomerase (tpi), toxin A (tcdA), toxin B (tcdB), binary toxin A (cdtA), and binary toxin B (cdtB). A subset of fecal specimens (n=62) with Ct values ≤ 25 for tcdB underwent total bacterial isolation in TCCFA and were processed for whole-genome shotgun sequencing. Based on the toxin gene profile of each isolate, MS infection was identified in 32.8% (57/174) of patients. Among all the isolates (N=522), tcdA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.